#USA #San Diego #Robles BioCeutics #Jorge Genovese #stem cell

Robles BioCeutics Appoints Jorge Genovese as Chief Scientific Officer

In a strategic move to enhance its clinical and scientific capabilities, Robles BioCeutics has announced the appointment of Dr. Jorge Genovese, MD, Ph.D., as the new Chief Scientific Officer. This development promises to propel the regenerative dermatology company towards an accelerated clinical translation of its stem cell-based pipeline.

Dr. Genovese, who brings a wealth of experience in tissue engineering and regenerative medicine, has previously held significant positions such as Principal Investigator at the McGowan Institute for Regenerative Medicine and Research Professor at the University of Pittsburgh. His expertise also extends to his role in leading the Cardiac Regenerative Medicine Laboratory at the University of Utah. With his extensive background, Dr. Genovese is positioned to oversee the scientific and clinical translation initiatives at Robles BioCeutics, aiming to innovate and expand its intellectual property portfolio managed by Knobbe Martens.

Expressing his enthusiasm for the role, Genovese stated, "I am thrilled to join Maria Robles and her exceptional team. Maria has built a scientific and intellectual property foundation that is second to none, and her rare combination of scientific insight and business acumen allows her to fluidly bridge the boardroom and laboratory. I look forward to helping Robles BioCeutics advance its groundbreaking regenerative and senolytic pipeline."

As a leader in regenerative dermatology, Robles BioCeutics is committed to developing solutions that enhance skin health and beauty. The company, founded by Maria Robles, integrates cutting-edge biotechnology to tap into the body’s natural regenerative capabilities. Under Genovese's stewardship, the firm is set to deepen its focus on anti-aging science and therapeutic innovations.

Dr. Genovese’s appointment signals a strategic alignments with the company’s ambition to advance its regenerative dermatology pipeline. His skills in skin biology, particularly in the production of keratinocytes, and his pioneering work on artificial skin, position him as a key figure in the company’s future endeavors.

Maria Robles, President and CEO of Robles BioCeutics, praised Dr. Genovese’s unparalleled contributions to the field and his vision which aligns with the company's commitment to advancing dermatological sciences. "We’re excited to shape the future of cosmetic science together with Dr. Genovese’s expertise," she remarked.

To further engage with the community and share knowledge about the fascinating world of stem cells in dermatology, Robles BioCeutics has released an educational video. This resource translates complex scientific concepts surrounding stem cells and their implications for skin health and anti-aging treatments into easily understood formats, fostering a better understanding among the general public.

Robles BioCeutics is on a mission to revolutionize the field of dermatology by providing innovative and scientifically driven solutions. With Dr. Genovese now at the helm of the scientific department, stakeholders and consumers alike can look forward to groundbreaking advancements that will redefine skin health and aesthetics.

For more updates on their latest initiatives and innovations, follow Robles BioCeutics on social media or visit their official website.